Unfolding the role of protein misfolding in neurodegenerative diseases (Q35038274)

5 August 2017

1 reference

title

Unfolding the role of protein misfolding in neurodegenerative diseases (English)

1 reference

5 August 2017

1 reference

Claudio Soto

1

1 reference

PubMed ID

12511861

5 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Nature Reviews Neuroscience

5 August 2017

1 reference

5 August 2017

4

1 reference

5 August 2017

49-60

1 reference

5 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn1007

5 August 2017

0 references

cites work

Conformational disease

1 reference

Protein misfolding, evolution and disease

31 March 2020

1 reference

Protein misfolding and disease; protein refolding and therapy

31 March 2020

1 reference

Molecular basis of the neurodegenerative disorders

31 March 2020

1 reference

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

31 March 2020

1 reference

Alpha-synuclein in Lewy bodies

31 March 2020

1 reference

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

31 March 2020

1 reference

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

31 March 2020

1 reference

Identification of a protein that purifies with the scrapie prion.

31 March 2020

1 reference

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

31 March 2020

1 reference

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

31 March 2020

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

31 March 2020

1 reference

Genetic classification of primary neurodegenerative disease.

31 March 2020

1 reference

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

31 March 2020

1 reference

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

31 March 2020

1 reference

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

31 March 2020

1 reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

31 March 2020

1 reference

Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome.

31 March 2020

1 reference

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

31 March 2020

1 reference

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

31 March 2020

1 reference

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

31 March 2020

1 reference

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

31 March 2020

1 reference

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

31 March 2020

1 reference

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

31 March 2020

1 reference

Spontaneous neurodegeneration in transgenic mice with mutant prion protein

31 March 2020

1 reference

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

31 March 2020

1 reference

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

31 March 2020

1 reference

31 March 2020

1 reference

Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

31 March 2020

1 reference

Transmissibility of systemic amyloidosis by a prion-like mechanism

31 March 2020

1 reference

Transmission of mouse senile amyloidosis

31 March 2020

1 reference

[URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae

31 March 2020

1 reference

Prions as protein-based genetic elements

31 March 2020

1 reference

Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

31 March 2020

1 reference

Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

31 March 2020

1 reference

Molecular structure of a fibrillar Alzheimer's A beta fragment.

31 March 2020

1 reference

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

31 March 2020

1 reference

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

31 March 2020

1 reference

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

31 March 2020

1 reference

Amyloid-like features of polyglutamine aggregates and their assembly kinetics

31 March 2020

1 reference

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

31 March 2020

1 reference

Alpha-helix structure in Alzheimer's disease aggregates of tau-protein.

31 March 2020

1 reference

Structural and kinetic features of amyloid beta-protein fibrillogenesis.

31 March 2020

1 reference

In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

31 March 2020

1 reference

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

31 March 2020

1 reference

The C-terminus of the beta protein is critical in amyloidogenesis

31 March 2020

1 reference

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

31 March 2020

1 reference

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4

31 March 2020

1 reference

Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro

31 March 2020

1 reference

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

31 March 2020

1 reference

Glutamine repeats and neurodegeneration

31 March 2020

1 reference

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

31 March 2020

1 reference

Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases

31 March 2020

1 reference

A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion

31 March 2020

1 reference

Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology

31 March 2020

1 reference

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

31 March 2020

1 reference

Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution.

31 March 2020

1 reference

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

31 March 2020

1 reference

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

31 March 2020

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

31 March 2020

1 reference

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

31 March 2020

1 reference

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

31 March 2020

1 reference

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

31 March 2020

1 reference

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

31 March 2020

1 reference

Neuron numbers in Alzheimer's disease: cell-specific pathology.

31 March 2020

1 reference

Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus

31 March 2020

1 reference

Neuronal apoptosis in Creutzfeldt-Jakob disease.

31 March 2020

1 reference

Apoptosis in neurodegenerative disorders

31 March 2020

1 reference

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

31 March 2020

1 reference

Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function.

31 March 2020

1 reference

Loss of normal huntingtin function: new developments in Huntington's disease research

31 March 2020

1 reference

Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice

31 March 2020

1 reference

Cellular prion protein: on the road for functions

31 March 2020

1 reference

Cellular prion protein transduces neuroprotective signals

31 March 2020

1 reference

Prions prevent neuronal cell-line death.

31 March 2020

1 reference

The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system

31 March 2020

1 reference

Prion protein protects human neurons against Bax-mediated apoptosis

31 March 2020

1 reference

Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis

31 March 2020

1 reference

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

31 March 2020

1 reference

Mice deficient for the amyloid precursor protein gene.

31 March 2020

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

31 March 2020

1 reference

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

31 March 2020

1 reference

Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.

31 March 2020

1 reference

Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration

31 March 2020

1 reference

31 March 2020

Metals and neuroscience.

1 reference

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

31 March 2020

1 reference

Neurotoxicity of a prion protein fragment.

31 March 2020

1 reference

A cellular model that recapitulates major pathogenic steps of Huntington's disease

31 March 2020

1 reference

Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments

31 March 2020

1 reference

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

31 March 2020

1 reference

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

31 March 2020

1 reference

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

31 March 2020

1 reference

Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly.

31 March 2020

1 reference

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

31 March 2020

1 reference

Channel formation by a neurotoxic prion protein fragment

31 March 2020

1 reference

Hydrogen peroxide mediates amyloid beta protein toxicity

31 March 2020

1 reference

alpha-synuclein promotes mitochondrial deficit and oxidative stress

31 March 2020

1 reference

Contribution of somal Lewy bodies to neuronal death.

31 March 2020

1 reference

Neurofibrillary degeneration and neuronal loss in Alzheimer's disease

31 March 2020

1 reference

A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

31 March 2020

1 reference

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

31 March 2020

1 reference

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

31 March 2020

1 reference

Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

31 March 2020

1 reference

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

31 March 2020

1 reference

Polyglutamine protein aggregates are dynamic

31 March 2020

1 reference

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

31 March 2020

1 reference

Inflammation in neurodegenerative disease--a double-edged sword

31 March 2020

1 reference

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

31 March 2020

1 reference

Early and progressive accumulation of reactive microglia in the Huntington disease brain

31 March 2020

1 reference

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

31 March 2020

1 reference

Reactive microglia in Creutzfeldt-Jakob disease

31 March 2020

1 reference

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

31 March 2020

1 reference

Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines.

31 March 2020

1 reference

Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia

31 March 2020

1 reference

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

31 March 2020

1 reference

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

31 March 2020

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

31 March 2020

1 reference

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

31 March 2020

1 reference

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

31 March 2020

1 reference

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

31 March 2020

1 reference

Nicotine inhibits amyloid formation by the beta-peptide.

31 March 2020

1 reference

Inhibiting transthyretin amyloid fibril formation via protein stabilization

31 March 2020

1 reference

Protein engineering as a strategy to avoid formation of amyloid fibrils

31 March 2020

1 reference

Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin

31 March 2020

1 reference

Trans-suppression of misfolding in an amyloid disease.

31 March 2020

1 reference

Dominant-negative inhibition of prion replication in transgenic mice

31 March 2020

1 reference

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

31 March 2020

1 reference

Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

31 March 2020

1 reference

Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides

31 March 2020

1 reference

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis

31 March 2020

1 reference

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

31 March 2020

1 reference

Interventional strategies against prion diseases

31 March 2020

1 reference

Therapeutic strategies for human amyloid diseases

31 March 2020

1 reference

The challenge of inhibiting Abeta polymerization

31 March 2020

1 reference

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

31 March 2020

1 reference

Immunization delays the onset of prion disease in mice.

31 March 2020

1 reference

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

31 March 2020

1 reference

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

31 March 2020

1 reference

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

31 March 2020

1 reference

Amyloid fibrils from muscle myoglobin

31 March 2020

1 reference

Amyloid fibril formation by a helical cytochrome.

31 March 2020

1 reference

Neuropathology of Parkinson's disease

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN1007

1 reference

5 August 2017

1 reference

PubMed ID

12511861